TP53 and glioblastoma: In a meta-analysis, the TP53 rs1042522 C>G polymorphism was found to be negatively associated with the risk of glioblastoma in the overall analysis, as well as stratified analyses by ethnic subgroups, control sources, and glioma subtypes [41].